SCHEMBL13192014

SCHEMBL13192014

COCCOc1cc(CP)ccc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 5/20 0.51
ALDH1A1 P00352 4/20 0.51
POLB P06746 2/20 0.51
MAPT P10636 2/20 0.51
HPGD P15428 2/20 0.51
MEN1 O00255 1/20 0.51
USP2 O75604 1/20 0.51
CYP2C9 P11712 1/20 0.51
ALOX12 P18054 1/20 0.51
MAPK1 P28482 1/20 0.51
CYP2C19 P33261 1/20 0.51
KMT2A Q03164 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
LMNA P02545 1/20 0.39
TRPV1 Q8NER1 1/20 0.38
HTR2C P28335 2/20 0.38
SLC6A4 P31645 2/20 0.38
HTR2B P41595 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14795018 0.85 L3MBTL1 (0.49) L3MBTL1ALDH1A1POLBMAPTHPGD
SCHEMBL1345879 0.83 L3MBTL1 (0.47) L3MBTL1ALDH1A1POLBMAPTHPGD
SCHEMBL11957393 0.83 L3MBTL1 (0.47) L3MBTL1ALDH1A1POLBMAPTHPGD
SCHEMBL27798475 0.81 L3MBTL1 (0.45) L3MBTL1ALDH1A1POLBMAPTHPGD
SCHEMBL12876995 0.80 SLC6A4 (0.38) L3MBTL1ALDH1A1POLBMAPTHPGD
SCHEMBL17709357 0.80 MEN1 (0.54) L3MBTL1ALDH1A1POLBMAPTHPGD
SCHEMBL22596995 0.79 L3MBTL1 (0.50) L3MBTL1ALDH1A1POLBMAPTHPGD
SCHEMBL13861973 0.77 L3MBTL1 (0.75) L3MBTL1ALDH1A1POLBMAPTHPGD
SCHEMBL16973454 0.76 PNMT (0.43) L3MBTL1ALDH1A1POLBMAPTHPGD
SCHEMBL16930307 0.76 PNMT (0.43) L3MBTL1ALDH1A1POLBMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120259122-A1 BENZYLPIPERIZINE COMPOUND DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-10-11 US disclosed
WO-2009099087-A1 BENZYLPIPERIZINE COMPOUND DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2009-08-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120259122-A1 BENZYLPIPERIZINE COMPOUND OPRM1, GRM1, CHRM1 L3MBTL1 932/4885ALDH1A1 1260/4885POLB 1672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.